Clinical Research Directory
Browse clinical research sites, groups, and studies.
Imaging Study in Metastatic Clear Cell RCC.
Sponsor: RayzeBio, Inc.
Summary
This imaging study aims to assess the feasibility, biodistribution, and dosimetry of the imaging agent in Subjects with Metastatic Clear Cell Renal Cell Cancer (RCC).
Official title: A Phase 0 Imaging Study to Assess the Feasibility, Biodistribution, and Dosimetry of the Imaging Agent in Subjects With Metastatic Clear Cell Renal Cell Cancer (RCC).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-06-15
Completion Date
2027-02
Last Updated
2026-10-13
Healthy Volunteers
No
Interventions
RYZ512
Imaging Agent
Locations (6)
Research Facility
Saint Leonards, New South Wales, Australia
Research Facility
Nedlands, Australia
Research Facility
Perth, Australia
Research Facility
Christchurch, New Zealand
Research Facility
Johannesburg, South Africa
Research Facility
Pretoria, South Africa